08/13/2025
9:18 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2025
8:15 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
12:52 PM | De La Rosa Abel (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
12:56 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Walsh Angela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
12:58 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Keefer David R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:00 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Duncan Gregory Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:02 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Thomas John C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:05 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Grosswald Ralph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:07 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Whitley Richard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
1:11 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Gendreau Roger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:01 PM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for DWTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Dogwood Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/24/2025
9:15 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
10:57 AM | De La Rosa Abel (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
10:59 AM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Thomas John C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
11:02 AM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Keefer David R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
11:04 AM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Whitley Richard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
11:15 PM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form EFFECT | |
05/23/2025
4:25 PM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/09/2025
10:28 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
8:20 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
1:08 PM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form ARS | |
04/30/2025
7:00 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form DEF 14A | |
04/03/2025
8:10 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
3:44 PM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2025
7:19 PM | Conjoint Inc. (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/17/2025
8:11 PM | Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Sealbond Ltd (Filed by)
| Form SCHEDULE 13D/A | |
03/17/2025
8:07 PM | CK Life Sciences Intl Inc (0001297567) (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:53 PM | Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Orca Capital AG (Filed by)
| Form SCHEDULE 13G/A | |
03/17/2025
4:49 PM | Dogwood Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Orca Capital AG (Filed by)
| Form SCHEDULE 13G | |
03/14/2025
10:47 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
9:32 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 424B5 | |
03/12/2025
8:00 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
8:30 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K/A | |
11/21/2024
8:15 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:15 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:15 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
8:25 AM | Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:29 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Toh Kean Meng Melvin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2024
3:30 PM | Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Yu Ying Choi Alan Abel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2024
3:29 PM | CK Life Sciences Intl Inc (0001297567) (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Sealbond Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/15/2024
3:19 PM | Sealbond Ltd (Filed by)
Virios Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
| Form SC 13D | |
Elon Musk’s New Technology (Ad) Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation.
You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth. Get the full details on the AI company behind Musk’s next big move. |
10/07/2024
7:06 AM | Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form DEFA14A | |
10/07/2024
7:02 AM | Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access